Brian Kidd - National HealthCare President
| NHC Stock | USD 91.28 0.51 0.56% |
President
Mr. Brian F. Kidd is a Senior Vice President, Controller and Principal Accounting Officer of the Company, effective January 1, 2017. He was with NHC since 2008. His responsibilities at NHC have included overseeing and reviewing all aspects of external financial reporting, which includes compliance and monitoring of GAAP and US Securities and Exchange Commission requirements. Mr. Kidd has also overseen Federal and State tax issues and SarbanesOxley compliance for NHC. Prior to joining NHC, Mr. Kidd was in public accounting for 10 years since 2017.
| Age | 49 |
| Tenure | 7 years |
| Professional Marks | CPA |
| Address | 100 East Vine Street, Murfreesboro, TN, United States, 37130 |
| Phone | 615 890 2020 |
| Web | https://www.nhccare.com |
National HealthCare Management Efficiency
The company has Return on Asset of 0.0248 % which means that on every $100 spent on assets, it made $0.0248 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.073 %, implying that it generated $0.073 on every 100 dollars invested. National HealthCare's management efficiency ratios could be used to measure how well National HealthCare manages its routine affairs as well as how well it operates its assets and liabilities. At present, National HealthCare's Return On Assets are projected to slightly decrease based on the last few years of reporting. At present, National HealthCare's Return On Tangible Assets are projected to slightly decrease based on the last few years of reporting. The current year's Intangibles To Total Assets is expected to grow to 0.14, whereas Total Assets are forecasted to decline to about 772 M.Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Kenneth Fasola | Centene Corp | 64 | |
| Christopher Koster | Centene Corp | 59 | |
| Cynthia Brinkley | Centene Corp | 57 | |
| Mark Boxer | Cigna Corp | 59 | |
| Adam PharmD | Cigna Corp | N/A | |
| Holly Benson | Centene Corp | N/A | |
| Brain Evanko | Cigna Corp | 40 | |
| Eric Palmer | Cigna Corp | 48 | |
| Lisa Bacus | Cigna Corp | 53 | |
| MD MBA | Humana Inc | 50 | |
| Susan Diamond | Humana Inc | 50 | |
| William Fleming | Humana Inc | 53 | |
| CHRISTOPHER HOCEVAR | Cigna Corp | 43 | |
| Regina Nethery | Humana Inc | N/A | |
| Dean Mirabella | Cigna Corp | N/A | |
| Christopher Todoroff | Humana Inc | 54 | |
| Claudio Abreu | Centene Corp | N/A | |
| George II | Humana Inc | 55 | |
| Nicole Jones | Cigna Corp | 53 | |
| Michael Phillips | Cigna Corp | N/A | |
| Andrew Asher | Centene Corp | 55 | |
Management Performance
| Return On Equity | 0.073 | ||||
| Return On Asset | 0.0248 |
National HealthCare Leadership Team
Elected by the shareholders, the National HealthCare's board of directors comprises two types of representatives: National HealthCare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of National. The board's role is to monitor National HealthCare's management team and ensure that shareholders' interests are well served. National HealthCare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, National HealthCare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Robert Adams, Non-Executive Chairman of the Board | ||
| Leroy McIntosh, Senior Vice President- Ancillary Services And Service Line Strategy. | ||
| W Adams, Director | ||
| David Lassiter, Senior Vice President - Corporate Affairs | ||
| Stephen Flatt, Chief Executive Officer, Director | ||
| Richard LaRoche, Independent Director | ||
| Emil Hassan, Independent Director | ||
| Andrew Adams, Director | ||
| Donald Daniel, Senior Vice President Principal Accounting Officer, Controller | ||
| Carl Adams, Founder | ||
| J Abernathy, Independent Director | ||
| Vicki Dodson, Senior Vice President - Patient Services | ||
| Josh McCreary, Senior Vice President General Counsel, Secretary | ||
| R Ussery, President, Chief Operating Officer | ||
| B Flatt, Senior Vice President, Chief Information Officer | ||
| John Lines, Senior Vice President General Counsel, Secretary | ||
| Brian Kidd, Senior Vice President Principal Accounting Officer, Controller | ||
| Julia Powell, Senior Vice President - Patient Services | ||
| Ernest Burgess, Independent Director | ||
| Michael Ussery, President, Chief Operating Officer | ||
| Anderson Flatt, Senior Vice President CIO | ||
| Jeffrey Smith, Senior Vice President Treasurer | ||
| Charlotte Swafford, Sr. VP and Treasurer | ||
| Anderson Sr, Senior Officer | ||
| Paul Abernathy, Independent Director | ||
| Gerald Coggin, Senior Vice President - Ancillary Services & Corporate Relations | ||
| Lawrence Tucker, Independent Director |
National Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is National HealthCare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.073 | ||||
| Return On Asset | 0.0248 | ||||
| Profit Margin | 0.06 % | ||||
| Operating Margin | 0.05 % | ||||
| Current Valuation | 1.27 B | ||||
| Shares Outstanding | 15.4 M | ||||
| Shares Owned By Insiders | 19.59 % | ||||
| Shares Owned By Institutions | 57.73 % | ||||
| Number Of Shares Shorted | 513.97 K | ||||
| Price To Earning | 22.85 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards National HealthCare in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, National HealthCare's short interest history, or implied volatility extrapolated from National HealthCare options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National HealthCare. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. For information on how to trade National Stock refer to our How to Trade National Stock guide.Note that the National HealthCare information on this page should be used as a complementary analysis to other National HealthCare's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for National Stock analysis
When running National HealthCare's price analysis, check to measure National HealthCare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy National HealthCare is operating at the current time. Most of National HealthCare's value examination focuses on studying past and present price action to predict the probability of National HealthCare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move National HealthCare's price. Additionally, you may evaluate how the addition of National HealthCare to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |
Is National HealthCare's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National HealthCare. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National HealthCare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 3.469 | Dividend Share 2.34 | Earnings Share 4.34 | Revenue Per Share 74.154 | Quarterly Revenue Growth 0.116 |
The market value of National HealthCare is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National HealthCare's value that differs from its market value or its book value, called intrinsic value, which is National HealthCare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National HealthCare's market value can be influenced by many factors that don't directly affect National HealthCare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between National HealthCare's value and its price as these two are different measures arrived at by different means. Investors typically determine if National HealthCare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National HealthCare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.